Related references
Note: Only part of the references are listed.Pathophysiology of heparan sulphate: many diseases, few drugs
U. Lindahl et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Factor H and Properdin Recognize Different Epitopes on Renal Tubular Epithelial Heparan Sulfate
Azadeh Zaferani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Basic and Translational Concepts of Immune-Mediated Glomerular Diseases
William G. Couser
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Proteoglycan sequence
Lingyun Li et al.
MOLECULAR BIOSYSTEMS (2012)
The role of complement in antibody-mediated rejection in kidney transplantation
Mark D. Stegall et al.
NATURE REVIEWS NEPHROLOGY (2012)
The Benefit of Targeted and Selective Inhibition of the Alternative Complement Pathway for Modulating Autoimmunity and Renal Disease in MRL/lpr Mice
Hideharu Sekine et al.
ARTHRITIS AND RHEUMATISM (2011)
Identification of Tubular Heparan Sulfate as a Docking Platform for the Alternative Complement Component Properdin in Proteinuric Renal Disease
Azadeh Zaferani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Alternative complement pathway assessment in patients with atypical HUS
Lubka T. Roumenina et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
New Roles for Innate Immune Response in Acute and Chronic Kidney Injuries
G. M. Goncalves et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Binding of the Human Complement Regulators CFHR1 and Factor H by Streptococcal Collagen-like Protein 1 (Scl1) via Their Conserved C Termini Allows Control of the Complement Cascade at Multiple Levels
Michael Reuter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Functional Characterization of the Recombinant Human C1 Inhibitor Serpin Domain: Insights into Heparin Binding
Veronique Rossi et al.
JOURNAL OF IMMUNOLOGY (2010)
Targeted Complement Inhibitors Protect against Posttransplant Cardiac Ischemia and Reperfusion Injury and Reveal an Important Role for the Alternative Pathway of Complement Activation
Carl Atkinson et al.
JOURNAL OF IMMUNOLOGY (2010)
Molecular Mechanisms of Chronic Kidney Transplant Rejection via Large-Scale Proteogenomic Analysis of Tissue Biopsies
Aleksey Nakorchevsky et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
C3 glomerulopathy: a new classification
Fadi Fakhouri et al.
NATURE REVIEWS NEPHROLOGY (2010)
Toward the assembly of heparin and heparan sulfate oligosaccharide libraries: efficient synthesis of uronic acid and disaccharide building blocks
Akihiro Saito et al.
TETRAHEDRON (2010)
Low-molecular-weight heparin inhibition in classical complement activaton pathway during pregnancy
Roxana Oberkersch et al.
THROMBOSIS RESEARCH (2010)
Heparan sulfate proteoglycans: structure, protein interactions and cell signaling
Juliana L. Dreyfuss et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2009)
The innate immune response in ischemic acute kidney injury
Hye Ryoun Jang et al.
CLINICAL IMMUNOLOGY (2009)
The Heparan Sulfate Proteoglycan Form of Epithelial CD44v3 Serves as a CD11b/CD18 Counter-receptor during Polymorphonuclear Leukocyte Transepithelial Migration
Ke Zen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Complement regulators and inhibitory proteins
Peter F. Zipfel et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival
A. G. Lewis et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Cellular uptake of C4b-binding protein is mediated by heparan sulfate proteoglycans and CD91/LDL receptor-related protein
Patricia P. Spijkers et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis
Claudia Kemper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Complement and renal transplantation: From donor to recipient
Jeffrey Damman et al.
TRANSPLANTATION (2008)
Binding between the Integrin αXβ2 (CD11c/CD18) and heparin
Thomas Vorup-Jensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly
Dirk Spitzer et al.
JOURNAL OF IMMUNOLOGY (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
How does proteinuria cause progressive renal damage?
Mauro Abbate et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Allograft rejection: effect of local synthesis of complement
SH Sacks et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans
C Noti et al.
CHEMISTRY & BIOLOGY (2005)
Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein
JL McRae et al.
JOURNAL OF IMMUNOLOGY (2005)
Heparan sulfate-protein interactions: therapeutic potential through structure-function insights
DR Coombe et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Differential substrate and inhibitor profiles for human MASP-1 and MASP-2
JS Presanis et al.
MOLECULAR IMMUNOLOGY (2004)
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation
G Girardi et al.
NATURE MEDICINE (2004)
The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury
B de Vries et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells
T Laumonier et al.
TRANSPLANTATION (2003)
Complement in renal transplantation
P Chowdhury et al.
NEPHRON CLINICAL PRACTICE (2003)
Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice
JM Thurman et al.
JOURNAL OF IMMUNOLOGY (2003)
A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats
TV Arumugam et al.
KIDNEY INTERNATIONAL (2003)
Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type I and type 2 diabetic patients:: The Di.NAS randomized trial
G Gambaro et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction
EJ Heyer et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2002)
Intrarenal synthesis of complement
WD Zhou et al.
KIDNEY INTERNATIONAL (2001)